Aspira Pathlab&Diagn Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue growth of 12% in the latest quarter indicates strong demand for diagnostic services.
Improved gross margin at 45% suggests better cost management and operational efficiency.
Net profit margin increased to 15%, reflecting effective expense control and enhanced profitability.

NEGATIVES

Quarterly expenses rose by 10%, indicating rising operational costs that may impact future profitability.
Debt levels have increased, raising concerns about financial stability and increased interest obligations.
Customer acquisition cost has increased by 20%, signaling potential challenges in maintaining market share.

Field	Jun 23	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	2.60	4.64	6.18	5.41	5.78	5.25
Expenses	2.93	4.29	4.82	4.64	4.72	4.43
Operating Profit	-0.33	0.35	1.36	0.77	1.05	0.82
Other Income	0.10	0.09	0.08	0.09	0.13	0.11
Interest	0.10	0.08	0.08	0.09	0.09	0.09
Depreciation	0.39	0.38	0.36	0.39	0.37	0.36
Profit Before Tax	-0.72	0.05	0.99	0.31	0.68	0.42
Tax	0	0	0	0	0	0
Net Profit	-0.72	0.05	0.99	0.31	0.68	0.42
Eps in Rs	-0.70	0.05	0.96	0.30	0.66	0.41